EUR/USD edges lower to near 1.1750 as Trump rejects new Iran peace offer The EUR/USD pair loses momentum to around 1.1765 during the early Asian session on Monday. The Euro (EUR) softens against the US Dollar (USD) amid a cautious mood after US President Donald Trump and I
The EUR/USD pair loses momentum to around 1.1765 during the early Asian session on Monday. The Euro (EUR) softens against the US Dollar (USD) amid a cautious mood after US President Donald Trump and Iran rejected each other’s latest peace proposals to end the war in the Mi
We had Chinese trade data over the weekend: China's April exports surge 14.1% as Iran war fear drives global stockpiling rush Today we get inflation data. China's deflation story appears to have run its course, with both consumer and producer prices having turned positive
RBC Capital increased its price target for CG Oncology shares, citing potential data from the PIVOT-006 trial in early June. RBC Capital raised its price target for CG Oncology (NASDAQ:CGON) to $79 from $73, maintaining an Outperform rating. The firm highlighted PIVOT-006
The synthetic DNA manufacturer reported 13 straight quarters of growth, driven by higher customer shipments and improved gross margins. Twist Bioscience posted Q2 2026 revenue of $110.7 million, a 19% increase from $92.8 million in the same period last year. The company at
Acadia Healthcare shares rise as two firms lift price targets following stronger-than-expected Q1 earnings and raised guidance. Acadia Healthcare (NASDAQ:ACHC) surged after RBC Capital raised its price target to $31 from $28 and maintained an Outperform rating. The upgrade
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best performing healthcare stocks so far in 2026. Revolution Medicines, Inc. (NASDAQ:RVMD) announced on May 1 that the U.S Food and Drug Administration (FDA) issued a “safe to proceed” letter to the company, all
Oruka Therapeutics, Inc. (NASDAQ:ORKA) is one of the best performing healthcare stocks so far in 2026. Leerink Partners lifted the price target on Oruka Therapeutics, Inc. (NASDAQ:ORKA) to $120 from $109 on April 30, reaffirming an Outperform rating on the shares In
Tango Therapeutics, Inc. (NASDAQ:TNGX) is one of the best performing healthcare stocks so far in 2026. Stifel lifted the price target on Tango Therapeutics, Inc. (NASDAQ:TNGX) to $40 from $24 on April 27, maintaining a Buy rating on the shares The firm cited elevate
Erasca, Inc. (NASDAQ:ERAS) is one of the best performing healthcare stocks so far in 2026. The Fly reported on May 4 that JPMorgan is maintaining an Overweight rating on Erasca, Inc. (NASDAQ:ERAS) and recommends buying the stock at current levels The firm believes t
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.